NASHVILLE, Tenn., Apr. 22, 2015 /PRNewswire-iReach/ — NueCura Partners, LLC has added the rapidly growing Denver based start-up, RxREVU, to its portfolio. “We’re tremendously excited to partner with RxREVU. Their software represents an extraordinary new approach to prescribing, and will greatly assist doctors and patients in finding the right medication at the right price,” says Ted Sanft, Operating Partner at NueCura.
RxREVU helps consumers and providers find the best drugs available based on cost, condition, and clinical research. Their mission is to help people live happier and healthier lives by finding the most effective treatment at the lowest cost. The company is trail-blazing the use of predictive analytics to help analyze medications based on unique patient factors, such as age, gender and ethnicity.
“Working with NueCura Partners was a great experience all around. Their team brings a deep understanding of the healthcare industry and clearly understands the need for our technology,” said Carm Huntress, CEO of RxREVU, Inc. “We’ve met with many early stage investment groups and could not be more impressed with the partners’ backgrounds, connectivity to the Nashville healthcare community and support they’ve already given us as an early stage company” said Huntress.
NueCura Partners, LLC is a Nashville-based angel investment group that focuses on early-stage investment opportunities in the healthcare sector. NueCura is managed by seasoned healthcare business operators and leverages their experience to identify and finance breakthrough technologies in the healthcare space. You can learn more about RxREVU at www.rxrevu.com.
Media Contact: Susan Francisco, RxREVU, Inc., (800) 360-4965, susan.francisco@rxrevu.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RxREVU